Zydus seeks DCGI approval for clinical trial of monoclonal antibodies cocktail
NEW DELHI: SARS-CoV-2 spike protein targeted, neutralizing monoclonal antibody based treatments have received emergency use authorization in mild COVID cases...
Clinical trial
India approves Phase II/III clinical trial of COVAXIN in age group of 2 to 18 Years
NEW DELHI: The National Regulator of India, the Drugs Controller General of India (DCGI), after careful examination, has accepted the...
